IBD: Ulcerative Colitis
Biosimilars for IBD: Making the Transition Webinar
On May 28th, Dr. McCurdy answered the following questions in a very informative webinar presentation on Biosimilars:
- What’s the difference between a reference biologic drug and a biosimilar?
- Biosimilars: What’s Health Canada saying?
- What is the clinical evidence to date?
- How do doctors go about transitioning their patients from a reference biologic drug to a biosimilar?
Watch this webinar now!
Related Articles
Making informed decisions is imperative to your good health but understanding the benefits and risks associated with Crohn’s Disease treatment options can be challenging. CDHF developed […]
Blackboards and Bathrooms was developed by the Canadian Digestive Health Foundation in collaboration with Robbies Rainbow. Blackboards and Bathrooms has been created especially for you – the […]
*Important: This is an opinion piece. This information should not be used as a substitute for the medical care and advice of your physician. There may […]